Top

Published in:

Open Access 01-10-2010 | Neuro

Neuromuscular imaging in inherited muscle diseases

Authors: Mike P. Wattjes, Rudolf A. Kley, Dirk Fischer

Published in: European Radiology | Issue 10/2010

Abstract

Driven by increasing numbers of newly identified genetic defects and new insights into the field of inherited muscle diseases, neuromuscular imaging in general and magnetic resonance imaging (MRI) in particular are increasingly being used to characterise the severity and pattern of muscle involvement. Although muscle biopsy is still the gold standard for the establishment of the definitive diagnosis, muscular imaging is an important diagnostic tool for the detection and quantification of dystrophic changes during the clinical workup of patients with hereditary muscle diseases. MRI is frequently used to describe muscle involvement patterns, which aids in narrowing of the differential diagnosis and distinguishing between dystrophic and non-dystrophic diseases. Recent work has demonstrated the usefulness of muscle imaging for the detection of specific congenital myopathies, mainly for the identification of the underlying genetic defect in core and centronuclear myopathies. Muscle imaging demonstrates characteristic patterns, which can be helpful for the differentiation of individual limb girdle muscular dystrophies. The aim of this review is to give a comprehensive overview of current methods and applications as well as future perspectives in the field of neuromuscular imaging in inherited muscle diseases. We also provide diagnostic algorithms that might guide us through the differential diagnosis in hereditary myopathies.

Mercuri E, Jungbluth H, Muntoni F (2005) Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 18:526–537CrossRefPubMed

Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F (2007) Muscle MRI in inherited neuromuscular disorders: past, present and future. J Magn Reson Imaging 25:433–440CrossRefPubMed

Peters SA, Köhler C, Schara U et al (2008) Muscular magnetic resonance imaging for evaluation of myopathies on children. Klin Pädiatr 220:37–46CrossRefPubMed

Klotzenburg M, Yousry T (2007) Magnetic resonance imaging of skeletal muscle. Curr Opin Neurol 20:595–599CrossRef

Fleckenstein JL, Crues JV III, Reimers CD (1996) Muscle imaging in health and disease. Springer, New York

Arts IM, Pillen S, Overeem S, Jurgen SH, Zwarts MJ (2007) Rise and fall of skeletal muscle size over the entire life span. J Am Geriatr Soc 55:1150–1152CrossRefPubMed

Kanehisa H, Ikegawa S, Tsunoda N, Fukunaga T (1994) Cross-sectional areas of fat and muscle in limbs during growth and middle age. In J Sports Med 15:420–425CrossRef

Brown M (2008) Skeletal muscle and bone: effect of sex steroids and ageing. Adv Physiol Educ 32:10–126

Doherty TJ (2003) Invited review: ageing and sacropenia. J Appl Physiol 95:717–727

10.

Pillen S, Arts IM, Zwarts MJ (2008) Muscle ultrasound in neuromuscular disorders. Muscle Nerve 37:679–693CrossRefPubMed

11.

Chi-Fishman G, Hicks JE, Cintas HM, Sonnies BC, Gerber LH (2004) Ultrasound imaging distinguishes between normal and weak muscles. Arch Phys Med Rehabil 85:980–986CrossRefPubMed

12.

Scheel AK, Reimers CD (2004) Detection of fasciculations and other types of muscular hyperkinesias with ultrasound. Ultraschall Med 25:337–341CrossRefPubMed

13.

Pillen S, Nienhuis M, van Dijk JP, Arts IM, van Alfen N, Zwarts MJ (2009) Muscles alive: ultrasound detects fibrillations. Clin Neurophysiol 120:932–936CrossRefPubMed

14.

Pillen S, Keimpema M, Bievelstein RAJ, Verrips A, Kruijsbergen-Raijmann W, Zwarts MJ (2006) Skeletal muscle ultrasonography: visual versus quantitative evaluation. Ultrasound Med Biol 32:1315–1321CrossRefPubMed

15.

Heckmatt JZ, Leeman S, Dubowitz V (1982) Ultrasound imaging in the diagnosis of muscle disease. J Pediatr 101:656–660CrossRefPubMed

16.

Pillen S, Scholten RR, Zwarts MJ, Verrips A (2003) Quantitative skeletal muscle ultrasonography in children with suspected neuromuscular disease. Muscle Nerve 27:142–147CrossRef

17.

Pohle R, Fischer D, von Rohden L (2000) Computer-supported tissue characterization in musculoskeletal ultrasonography. Ultraschall Med 21:245–252CrossRefPubMed

18.

Pillen S, van Dijk JP, Weijers G, Raijmann W, de Korte CL, Zwarts MJ (2009) Quantitative gray-scale analysis in skeletal muscle ultrasound: a comparison study of two ultrasound devices. Muscle Nerve 39:781–786CrossRefPubMed

19.

Pillen S, Verrips A, van Alfen N, Arts IM, Sie LT, Zwarts MJ (2007) Quantitative skeletal muscle ultrasound: diagnostic value in childhood neuromuscular disease. Neuromuscul Disord 17:509–516CrossRefPubMed

20.

Pillen S, Morava E, van Keimpema M, ter Laak HJ, de Vries MC, Rodenburg RJ (2006) Skeletal muscle ultrasonography in children with dysfunction in the oxidative phosphorylation system. Neuropediatrics 37:142–147CrossRefPubMed

21.

O’Sullivan PJ, Gorman GM, Hardiman OM, Farrel MJ, Logan PM (2006) Sonographically guided percutaneous muscle biopsy in diagnosis of neuromuscular disease: a useful alternative to open surgical biopsy. J Ultrasound Med 25:1–6PubMed

22.

Ozsarlak O, Schepens E, Parizel PM et al (2001) Hereditary neuromuscular diseases. Eur J Radiol 40:184–197CrossRefPubMed

23.

Schedel H, Reimers CD, Nägele M, Witt TN, Pongratz DE, Vogl T (1992) Imaging techniques in myotonic dystrophy: a comparative study of ultrasound, computed tomography and magnetic resonance imaging of skeletal muscles. Eur J Radiol 15:230–238CrossRefPubMed

24.

Alanen AM, Falck B, Kalimo H, Komu ME, Sonninen VH (1994) Ultrasound, computed tomography and magnetic resonance imaging in myopathies: correlation with electromyography and histopathology. Acta Neurol Scand 89:336–346CrossRefPubMed

25.

Mercuri E, Talim B, Moghadaszadeh B et al (2002) Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord 12:631–638CrossRefPubMed

26.

Fischer D, Kley RA, Strach K et al (2008) Distinct muscle imaging patterns in myofibrillar myopathies. Neurology 71:758–765CrossRefPubMed

27.

Kornblum C, Lutterbey G, Bogdanow M, Kesper K, Schild H, Schröder R, Wattjes MP (2006) Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2. A whole body highfield MRI study. J Neurol 253:753–761CrossRefPubMed

28.

Modolell I, Mearin F, Baudet JS, Gámez J, Cervera C, Malagelada JR (1999) Pharyngo-esophageal disturbances in patients with myotonic dystrophy. Scand J Gastroenterol 34:878–882CrossRefPubMed

29.

Strach K, Sommer T, Grohé C et al (2008) Clinical, genetic and cardiac magnetic resonance findings in primary desminopathies. Neuromuscul Disord 18:475–482CrossRefPubMed

30.

Straub V, Donahue KM, Allamand V, Davisson RL, Kim YR, Campbell KP (2000) Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. Magn Reson Med 44:655–659CrossRefPubMed

31.

Schmidt S, Vieweger A, Obst M et al (2009) Dysferlin-deficient muscular dystrophy: gadfluorine M suitability at MR imaging in a mouse model. Radiology 250:87–94CrossRefPubMed

32.

Heemskerk AM, Strijkers GJ, Vilanova A, Drost MR, Nicolay K (2005) Determination of mouse skeletal muscle architecture using three-dimensional diffusion tensor imaging. Magn Reson Med 53:1333–1340CrossRefPubMed

33.

Weber MA, Nielles-Vallespin S, Essig M, Jurkat-Rott K, Kauczor HU, Lehmann-Horn F (2006) Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness. Neurology 67:1151–1158CrossRefPubMed

34.

Hsieh TJ, Wang CK, Hy C, Jong YJ, Li CW, Liu GC (2007) In vivo proton magnetic resonance spectroscopy assessment for muscle metabolism in neuromuscular disorders. J Pediatr 151:319–321CrossRefPubMed

35.

Weber MA, Krix M, Delorme S (2007) Quantitative evaluation of muscle perfusion with CEUS and with MRI. Eur Radiol 17:2663–2674CrossRefPubMed

36.

Guglieri M, Straub V, Bushby K, Lochmüller H (2008) Limb-girdle muscular dystrophies. Curr Opin Neurol 21:576–584CrossRefPubMed

37.

Bonnemann CG, Finkel RS (2002) Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies. Semin Pediatr Neurol 9:81–99CrossRefPubMed

38.

Mercuri E, Brockington M, Straub V et al (2003) Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 53:537–542CrossRefPubMed

39.

Poppe M, Cree L, Bourke J et al (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60:1246–1251PubMed

40.

Fischer D, Walter MC, Kepser K et al (2005) Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 252:538–547CrossRefPubMed

41.

Mercuri E, Bushby K, Ricci E et al (2005) Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord 15:164–171CrossRefPubMed

42.

Liu J, Aoki M, Illa I et al (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Myoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20:31–36CrossRefPubMed

43.

Illa I, Serrano-Munuera C, Gallardo E et al (2001) Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 49:130–134CrossRefPubMed

44.

Illa I, De Luna N, Dominguez-Perles R et al (2007) Symptomatic dysferlin gene mutation carriers: characterization of two cases. Neurology 68:1284–1289CrossRefPubMed

45.

Cupler EJ, Bohlega S, Hessler R, McLean D, Stigsby B, Ahmad J (1998) Miyoshi myopathy in Saudi Arabia: clinical, electrophysiological, histopathological and radiological features. Neuromuscul Disord 8:321–326CrossRefPubMed

46.

Kesper K, Kornblum C, Reimann J, Lutterbey G, Schröder R, Wattjes MP (2009) Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study. Acta Neurol Scand 120:111–118CrossRefPubMed

47.

Eymard B, Romero NB, Leturcq F et al (1997) Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology 48:1227–1234PubMed

48.

Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63:946–950CrossRefPubMed

49.

Liu GC, Jong YJ, Chiang C, Jaw TS (1993) Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 186:475–480PubMed

50.

Lodi R, Muntoni F, Taylor J et al (1997) Correlative MR imaging and 31P-MR spectroscopy study in sarcoglycan deficient limb girdle muscular dystrophy. Neuromuscul Disord 7:505–511CrossRefPubMed

51.

Selcen D (2008) Myofibrillar myopathies. Curr Opin Neurol 21:585–589CrossRefPubMed

52.

Emery AE (1991) Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscul Disord 1:19–29CrossRefPubMed

53.

Castillo L, Pumar JM, Rodriguez JR et al (1993) Magnetic-resonance-imaging of muscles in myotonic dystrophy. Eur J Radiol 17:141–144CrossRefPubMed

54.

Damian MS, Bachmann G, Herrmann D, Dorndorf W (1993) Magnetic resonance imaging of muscle and brain in myotonic dystrophy. J Neurol 240:8–12CrossRefPubMed

55.

Serratrice G, Salamon G, Jiddane M, Gastaut JL, Pellissier JF, Pouget J (1985) Results of muscular x-ray computed tomography in 145 cases of neuromuscular disease. Rev Neurol (Paris) 141:404–412

56.

Tawil R, Van Der Maarel SM (2006) Facioscapulohumeral muscular dystrophy. Muscle Nerve 34:1–15CrossRefPubMed

57.

Olsen DB, Gideon P, Jeppesen TD, Vissing J (2006) Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. J Neurol 253:1437–1441CrossRefPubMed

58.

Kan HE, Scheenen TWJ, Wohlgemuth M et al (2009) Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 19:357–362CrossRefPubMed

59.

Brais B, Rouleau GA, Bouchard JP, Fardeau M, Tomé FMS (1999) Oculopharyngeal muscular dystrophy. Semin Neurol 19:59–66CrossRefPubMed

60.

King MK, Lee RR, Davis LE (2005) Magnetic resonance imaging and computed tomography of skeletal muscles in oculopharyngeal muscular dystrophy. J Clin Neuromuscul Dis 6:103–108CrossRefPubMed

61.

Fischer D, Herasse M, Ferreiro A et al (2006) Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene. Neurology 67:2217–2220CrossRefPubMed

62.

Jungbluth H, Davis MR, Muller C et al (2004) Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul Disord 14:785–790CrossRefPubMed

63.

Mercuri E, Lampe A, Allsop J et al (2005) Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. Neuromuscul Disord 15:303–310CrossRefPubMed

64.

Mercuri E, Cini C, Pichiecchio A et al (2003) Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul Disord 13:554–558CrossRefPubMed

65.

Fischer D, Herasse M, Bitoun M et al (2006) Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain 129:1463–1469CrossRefPubMed

66.

Jungbluth H, Sewry CA, Counsell S et al (2004) Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul Disord 14:779–784CrossRefPubMed

67.

Kornblum C, Lutterbey GG, Czermin B, Reimann J, von Kleist-Retzow JC, Jurkat-Rott K, Wattjes MP (2010) Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita. Acta Neurol Scand 121:131–135CrossRefPubMed

68.

Weber MA, Niellies-Vallespin S, Huttner HB et al (2006) Evaluation of patients with paramyotonica at ²³Na MR imaging during cold-induced weakness. Radiology 240:489–500CrossRefPubMed

69.

Pichiecchio A, Poloni GU, Ravaglia S et al (2009) Enzyme replacement therapy in adult- onset glycogenosis II. Is quantitative muscle MRI helpful? Muscle Nerve 40:122–125CrossRefPubMed

70.

Kornblum C, Schröder R, Müller K et al (2005) Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled double blind 31P-MRS crossover study. Eur J Neurol 12:300–309CrossRefPubMed

71.

Wattjes MP, Barkhof F (2009) High field MRI in the diagnosis of multiple sclerosis: high field-high yield? Neuroradiology 51:279–292CrossRefPubMed

72.

Willinek WA, Schild HH (2008) Clinical advantages of 3.0T MRI over 1.5T. Eur J Radiol 65:2–14CrossRefPubMed

73.

Bendzus M, Koltzenburg M (2001) Visualization of denervated muscle by gadolinium-enhanced MRI. Neurology 57:1709–1711

Title: Neuromuscular imaging in inherited muscle diseases
Authors: Mike P. Wattjes
Rudolf A. Kley
Dirk Fischer
Publication date: 01-10-2010
Publisher: Springer-Verlag
Published in: European Radiology / Issue 10/2010
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-010-1799-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Neuromuscular imaging in inherited muscle diseases

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2010

A 52-year-old man with palpable nodule in the right breast (2010: 10a)

Single breath-hold magnetic resonance cine imaging for fast assessment of global and regional left ventricular function in clinical routine

Optimising diffusion-weighted imaging in the abdomen and pelvis: comparison of image quality between monopolar and bipolar single-shot spin-echo echo-planar sequences

The sentence verification task: a reliable fMRI protocol for mapping receptive language in individual subjects

Assessment of liver steatosis in chicken by using acoustic radiation force impulse imaging: preliminary results

MR elastography of the liver at 3 T with cine-tagging and bending energy analysis: preliminary results